Cargando…

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?

OBJECTIVE: Remnant ablation with radioactive iodine (I-131) is a successful form of treatment that aims to destroy the remaining residual tissue and/or metastatic tissue after total thyroidectomy in differentiated thyroid cancer (DTC) patients. High level of thyroid stimulating hormone (TSH) (≥30 mI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasbek, Zekiye, Turgut, Bülent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096624/ https://www.ncbi.nlm.nih.gov/pubmed/27277324 http://dx.doi.org/10.4274/mirt.88598

Ejemplares similares

The Evaluation of Microcarcinoma in Differentiated Thyroid Cancers According to Old and New TNM Classification
por: Hasbek, Zekiye, et al.
Publicado: (2011)

Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type
por: Börksüz, Mehmet Fatih, et al.
Publicado: (2016)

Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
por: Babić Leko, Mirjana, et al.
Publicado: (2021)

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
por: Sohn, Seo Young, et al.
Publicado: (2015)

Effectiveness of Different Thyroid Stimulating Hormone Thresholds for Thyroid Hormone Withdrawal - Aided Radioiodine Ablation in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta - Analysis
por: Rojas, Tatiana, et al.
Publicado: (2021)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

The Effect of ThyroidߚStimulating Hormone on Stage of Differentiated Thyroid Carcinoma
por: Soleimanisardoo, Laya, et al.
Publicado: (2021)

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

The Difference in Thyroid Stimulating Hormone Levels between Differentiated Carcinoma and Benign Enlargement
por: Rianto, Bambang Udji Djoko, et al.
Publicado: (2020)

Association of Preoperative Serum Thyroid-stimulating Hormone Levels with Thyroid Cancer in Patients with Nodular Thyroid Disease
por: Khan, Muhammad Aleem, et al.
Publicado: (2017)

Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
por: Wang, Ruihua, et al.
Publicado: (2018)

A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
por: Xiao, Juan, et al.
Publicado: (2021)

Thyroid-stimulating hormone levels in children from Chernobyl.
por: Quastel, M R, et al.
Publicado: (1997)

Genetic associations with neonatal thyroid stimulating hormone levels
por: Alul, Farah Y., et al.
Publicado: (2013)

Thyroid Stimulating Hormone Receptor
por: Tuncel, Murat
Publicado: (2017)

Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery
por: Shuai, Jin-Hao, et al.
Publicado: (2023)

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
por: Wolfson, Robert M., et al.
Publicado: (2016)

The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Pak, Kyoungjune, et al.
Publicado: (2014)

The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer
por: Hasbek, Zekiye, et al.
Publicado: (2016)

Usefulness of Serum IgG4 and Thyroid Stimulating Hormone Levels in Differentiating Headache
por: Nakatsuji, Yoshiyuki, et al.
Publicado: (2022)

Regulation of Inhibitors of Differentiation Family Proteins by Thyroid-Stimulating Hormone in FRTL-5 Thyroid Cells
por: Jo, Young Suk, et al.
Publicado: (2008)

The Relationship Between HER-2 Expression Levels and (18)F-FDG PET/CT Parameters in Gastric Cancer
por: Ertürk, Seyit Ahmet, et al.
Publicado: (2021)

Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production
por: Ke, Sujie, et al.
Publicado: (2021)

"High normal" thyroid stimulating hormone: does it matter?
por: Chun, Hyunji, et al.
Publicado: (2013)

Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine‐treated cats
por: Wakeling, Jennifer, et al.
Publicado: (2020)

Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation
por: Fröhlich, Eleonore, et al.
Publicado: (2023)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Relationship Between Thyroid-Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Association of High Vitamin D Status with Low Circulating Thyroid-Stimulating Hormone Independent of Thyroid Hormone Levels in Middle-Aged and Elderly Males
por: Zhang, Qingqing, et al.
Publicado: (2014)

Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2015)

Thyroid-Stimulating Hormone Levels Are Positively Associated with Insulin Resistance
por: Zhu, Ping, et al.
Publicado: (2018)

The association between thyroid-stimulating hormone and thyroid nodules, goiter and thyroid antibody positivity
por: Li, Shaohan, et al.
Publicado: (2023)

The Relationships between Thyroid Hormones and Thyroid-stimulating Hormone with Lipid Profile in Euthyroid Men
por: Chin, Kok-Yong, et al.
Publicado: (2014)

Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer
por: Dewi, Ayu Rosemeilia, et al.
Publicado: (2017)

Roxadustat and thyroid-stimulating hormone suppression
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with (131)I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
por: Signore, Alberto, et al.
Publicado: (2022)

Neonatal thyroid screening: Relationship between cord blood thyroid stimulating hormone levels and thyroid stimulating hormone in heel prick sample on 4(th) to 7(th) day-of-life
por: Seth, Anju, et al.
Publicado: (2014)

Neonatal thyroid screening: Relationship between cord blood thyroid stimulating hormone levels and thyroid stimulating hormone in heel prick sample on 4(th) to 7(th) day-of-life
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2015)

C-reactive protein and thyroid-stimulating hormone levels as risk factors for hypothyroidism in patients with subacute thyroiditis
por: Tang, Chenjia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m2k5n7paojc3p9op6o5lpb0is3